EGFR and neoplasm: Repopulation depends on the activation of signaling pathways that stimulate the proliferation of tumor cells and many molecular-targeted agents have been developed that inhibit these pathways, such as gefitinib which targets epidermal growth factor receptor (EGFR) signaling [2].